• CRISPR–Cas9/long-read sequencing approach to identify cryptic mutations in BRCA1 and other tumour suppressor genes.
    • Walsh T, Casadei S, Munson KM, Eng M, Mandell JB, Gulsuner S, King MC.
    • J Med Genet. 2020 Oct 15:jmedgenet-2020-107320. doi: 10.1136/jmedgenet-2020-107320. Epub ahead of print.
    • Case report
    • Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations.
    • Rivera D, Paudice M, Gismondi V, Anselmi G, Vellone VG, Varesco L; Ligurian BRCA Working Group.
    • J Clin Pathol. 2020 Sep 7:jclinpath-2020-206840. doi: 10.1136/jclinpath-2020-206840. Epub ahead of print.
    • Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects.
    • Peixoto A, Pinto P, Guerra J, Pinheiro M, Santos C, Pinto C, Santos R, Escudeiro C, Bartosch C, Canário R, Barbosa A, Gouveia A, Petiz A, Abreu MH, Sousa S, Pereira D, Silva J, Teixeira MR.
    • Front Oncol. 2020 Jul 31;10:1318. doi: 10.3389/fonc.2020.01318.
  • LitAlert ~~ GeneLit.com

    • Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.
    • Park K, Kim MK, Lee T, Hong J, Kim HK, Ahn S, Lee YJ, Kim J, Lee SW, Lee JW, Lee W, Chun S, Son BH, Jung KH, Kim YM, Min WK, Ahn SH.
    • J Clin Lab Anal. 2020 Aug 19:e23524. doi: 10.1002/jcla.23524. Epub ahead of print.
    • [Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing].
    • Minucci A, Mazzuccato G, Marchetti C, Pietragalla A, Scambia G, Fagotti A, Urbani A.
    • Mol Biol (Mosk). 2020 May-Jun;54(4):688-698. Russian. doi: 10.31857/S0026898420040114.
    • [Article in Russian.]